Latest Euclidean Capital LLC Stock Portfolio
Euclidean Capital LLC Performance:
2025 Q2: 6.22%YTD: 1.29%2024: 12.47%
Performance for 2025 Q2 is 6.22%, and YTD is 1.29%, and 2024 is 12.47%.
About Euclidean Capital LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Euclidean Capital LLC reported an equity portfolio of $305.7 Millions as of 30 Jun, 2025.
The top stock holdings of Euclidean Capital LLC are VEU, AMPS, ORIC. The fund has invested 47.1% of it's portfolio in VANGUARD INTL EQUITY INDEX F and 44.2% of portfolio in ISHARES TR.
The fund managers got completely rid off RAPT THERAPEUTICS INC (RAPT) stocks. Euclidean Capital LLC opened new stock positions in RAPT THERAPEUTICS INC (RAPT). The fund showed a lot of confidence in some stocks as they added substantially to VANGUARD INTL EQUITY INDEX F (VEU).
The top stock holdings of Euclidean Capital LLC are VEU, AMPS, ORIC. The fund has invested 47.1% of it's portfolio in VANGUARD INTL EQUITY INDEX F and 44.2% of portfolio in ISHARES TR.
The fund managers got completely rid off RAPT THERAPEUTICS INC (RAPT) stocks. Euclidean Capital LLC opened new stock positions in RAPT THERAPEUTICS INC (RAPT). The fund showed a lot of confidence in some stocks as they added substantially to VANGUARD INTL EQUITY INDEX F (VEU).
Euclidean Capital LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Euclidean Capital LLC made a return of 6.22% in the last quarter. In trailing 12 months, it's portfolio return was 5.49%.
New Buys
| Ticker | $ Bought |
|---|---|
| rapt therapeutics inc | 657,872 |
New stocks bought by Euclidean Capital LLC
Additions
| Ticker | % Inc. |
|---|---|
| vanguard intl equity index f | 7.57 |
Additions to existing portfolio by Euclidean Capital LLC
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| rapt therapeutics inc | -802,637 |
Euclidean Capital LLC got rid off the above stocks
Sector Distribution
Euclidean Capital LLC has about 47.9% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 47.9 |
| Utilities | 44.2 |
| Healthcare | 7.9 |
Market Cap. Distribution
Euclidean Capital LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 48.1 |
| UNALLOCATED | 47.9 |
| MICRO-CAP | 3.7 |
Stocks belong to which Index?
About 51.8% of the stocks held by Euclidean Capital LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 51.8 |
| Others | 48.2 |
Euclidean Capital LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Euclidean Capital LLC
Euclidean Capital LLC has 11 stocks in it's portfolio. SRZN proved to be the most loss making stock for the portfolio. AMPS was the most profitable stock for Euclidean Capital LLC last quarter.
Last Reported on: 14 Aug, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALEC | alector inc | 0.60 | 1,307,860 | 1,831,000 | unchanged | 0.00 | ||
| AMPS | ishares tr | 44.17 | 2,425,140 | 135,032,000 | unchanged | 0.00 | ||
| FHTX | foghorn therapeutics inc | 2.42 | 1,573,760 | 7,396,680 | unchanged | 0.00 | ||
| ORIC | oric pharmaceuticals inc | 3.29 | 989,410 | 10,042,500 | unchanged | 0.00 | ||
| PMVP | pmv pharmaceuticals inc | 0.91 | 2,627,640 | 2,785,300 | unchanged | 0.00 | ||
| RAPT | rapt therapeutics inc | 0.22 | 82,234 | 657,872 | new | |||
| RAPT | rapt therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| SPY | spdr s&p 500 etf tr | 0.83 | 4,104 | 2,535,660 | unchanged | 0.00 | ||
| SRZN | surrozen inc | 0.26 | 87,696 | 784,002 | unchanged | 0.00 | ||
| SRZN | surrozen inc | 0.00 | 170,833 | 3,092 | unchanged | 0.00 | ||
| TNYA | tenaya therapeutics inc | 0.20 | 1,015,700 | 620,799 | unchanged | 0.00 | ||
| VEU | vanguard intl equity index f | 47.11 | 2,142,680 | 144,031,000 | added | 7.57 | ||